These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14533551)

  • 1. Atherosclerosis and HIV infection: diagnosis and treatment.
    Mooser V
    Adv Cardiol; 2003; 40():140-50. PubMed ID: 14533551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How HIV infection and its treatment affects the cardiovascular system: what is known, what is needed.
    Panther LA
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H1-4. PubMed ID: 12063267
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary artery disease in patients with HIV infection.
    Patel AA; Budoff MJ
    Am J Cardiovasc Drugs; 2015 Apr; 15(2):81-7. PubMed ID: 25672641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Premature arteriosclerosis in HIV-infected patients? Current status].
    Hoffmann C
    Herz; 2005 Sep; 30(6):467-71. PubMed ID: 16170676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased cardiovascular risk in HIV patients].
    Wierema TK
    Ned Tijdschr Geneeskd; 2010; 154():A788. PubMed ID: 20456808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atherosclerosis in HIV-positive patients].
    Neumann T; Miller M; Esser S; Gerken G; Erbel R
    Z Kardiol; 2002 Nov; 91(11):879-88. PubMed ID: 12442190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus (HIV) in older people.
    Pratt G; Gascoyne K; Cunningham K; Tunbridge A
    Age Ageing; 2010 May; 39(3):289-94. PubMed ID: 20190230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness?
    Schillaci G; Pucci G; De Socio GV
    Am J Hypertens; 2009 Aug; 22(8):817-8. PubMed ID: 19638954
    [No Abstract]   [Full Text] [Related]  

  • 10. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV in the older adult.
    Oyieng'o DO; Bradley J
    Med Health R I; 2010 Aug; 93(8):252-3. PubMed ID: 20827933
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction to HIV infection and HIV neurology.
    Brew BJ
    Handb Clin Neurol; 2018; 152():1-2. PubMed ID: 29604969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
    Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M
    Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on HIV related epidemiological research.
    Dukers NH; Prins M; Coutinho RA
    Eur J Epidemiol; 2004; 19(6):509-11. PubMed ID: 15330121
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary HIV infection.
    Miles K
    Community Pract; 2005 Sep; 78(9):331-3. PubMed ID: 16187668
    [No Abstract]   [Full Text] [Related]  

  • 16. The changing epidemiology of HIV infection: new challenges for HIV palliative care.
    Easterbrook P; Meadway J
    J R Soc Med; 2001 Sep; 94(9):442-8. PubMed ID: 11535745
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular risk in HIV infected patients].
    Raimundo P; Miranda A; Ribeiro J; Mansinho K
    Acta Med Port; 2010; 23(4):669-76. PubMed ID: 20687996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of atherosclerosis.
    Popa C; Tufănoiu E
    Rom J Neurol Psychiatry; 1991; 29(1-2):71-9. PubMed ID: 1892781
    [No Abstract]   [Full Text] [Related]  

  • 19. A turning point: The new World Health Organization guidelines for treatment of human immunodeficiency virus infection.
    Kulkarni V
    Indian J Dermatol Venereol Leprol; 2016; 82(2):125-7. PubMed ID: 26924400
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
    Haser GC; Sumpio B
    J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.